Pathogenic fungi have emerged as significant causes of infectious morbidity and death in
patients with acquired immunodeficiency conditions such as HIV/AIDS and following receipt …

Vaccines comprising innovative adjuvants are rapidly reaching advanced translational
stages, such as the authorized nanotechnology adjuvants in mRNA vaccines against COVID …

The remarkable success of messenger RNA (mRNA) vaccines against severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2) has propelled the rapid development of …

The paucity of blood granulocyte populations such as neutrophils in laboratory mice is a
notable difference between this model organism and humans, but the cause of this species …

The approved worldwide use of two messenger RNA (mRNA) vaccines (BNT162b2 and
mRNA-1273) in late 2020 has proven the remarkable success of mRNA therapeutics …

Highlights•Adjuvants can be incorporated into vaccines to enhance the magnitude,
functionality, breadth and durability of antigen-specific immune responses.•A deeper …

With the rapid growth of advanced nanoengineering strategies, there are great implications
for therapeutic immunostimulators formulated in nanomaterials to combat cancer. It is crucial …

Pathogens or danger signals trigger the immune response. Moderate immune response
activation removes pathogens and avoids excessive inflammation and tissue damage …

Several recent attempts to improve the stability and immunogenicity of messenger RNA
(mRNA) vaccines include the use of circular RNA (circRNA), targeted delivery, and …

Vaccines remain one of the most important pillars in preventative medicine, providing
protection against a wide array of diseases by inducing humoral and/or cellular immunity. Of …